• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Positioning Problem (3009)
Patient Problem No Code Available (3191)
Event Date 10/07/2019
Event Type  Injury  
Event Description
It was reported that the stent deployed in the wrong location.A 7x120x75 eluvia drug-eluting vascular stent system was selected for a procedure in the heavily calcified, non-tortuous, 40-50% stenosed superficial femoral artery (sfa).During the procedure, the delivery system was advanced over a guidewire and positioned in the usual way over the lesion.Deployment was initiated with the thumbwheel.After a few centimeters of deployment, the entire stent launched forward uncontrollably off of the delivery system.The stent deployed in the wrong location.An additional eluvia stent was placed which resulted in a satisfactory result for the patient.There were no patient complications and the patient status was good post procedure.
 
Manufacturer Narrative
Device evaluated by mfr: returned product consisted of an eluvia self-expanding stent system.The inner liner and tip of the device was checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.There is a kink to the inner liner 13.8cm from the tip.Microscopic examination revealed no additional damages.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Event Description
It was reported that the stent deployed in the wrong location.A 7x120x75 eluvia drug-eluting vascular stent system was selected for a procedure in the heavily calcified, non-tortuous, 40-50% stenosed superficial femoral artery (sfa).During the procedure, the delivery system was advanced over a guidewire and positioned in the usual way over the lesion.Deployment was initiated with the thumbwheel.After a few centimeters of deployment, the entire stent launched forward uncontrollably off of the delivery system.The stent deployed in the wrong location.An additional eluvia stent was placed which resulted in a satisfactory result for the patient.There were no patient complications and the patient status was good post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9266058
MDR Text Key164620981
Report Number2134265-2019-13263
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023447159
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/14/2019
Initial Date Manufacturer Received 10/10/2019
Initial Date FDA Received11/01/2019
Supplement Dates Manufacturer Received11/19/2019
Supplement Dates FDA Received11/19/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-